HOME >> BIOLOGY >> NEWS
GroPep infertility data presented at US meeting

crinology have arisen by the discovery and clinical application of defined hormones. These data demonstrate the very real possibility of pharmacotherapy for recurrent miscarriage using a defined agent. Now clinical reproductive immunology may be able to move forward."

GroPep is currently undertaking additional pre-clinical work in preparation for a Phase 1 clinical trial. Studies aimed at optimising the PV903 formulation as well as defining clinical endpoints will underpin the clinical program planned to commence in Adelaide in 2006.

GroPep advised on December 20, 2004 that it intends to proceed with the PV903 project towards a Phase 1 clinical trial. This latest data confirms that position.


'"/>

Contact: Mr Tony Mitchell
investorrelations@gropep.com.au
61-8-8354-7700
Research Australia
13-Jun-2005


Page: 1 2

Related biology news :

1. GroPep announces US FDA approval of biopharmaceutical that uses its cell culture product
2. GroPep announces Japanese approval of biopharmaceutical that uses its cell culture products
3. Male or female factor infertility -- men suffer just the same
4. Risk-taking in infertility treatment correlates with womens negative moods
5. New research holds promise for protecting cancer patients against infertility
6. Stressed-out African naked mole-rats may provide clues about human infertility
7. Key to male infertility
8. Researchers find gene mutation that causes infertility in male mice
9. Treating male infertility with stem cells
10. Eating ice cream may help women to conceive, but low-fat dairy foods may increase infertility risk
11. World-first stem cell research could aid male infertility

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2019)... ... August 20, 2019 , ... ... second time since BioInformatics first fielded the survey in 2016. The results ... Experience , from BioInformatics, part of Science and Medicine Group. More than 800 ...
(Date:8/15/2019)... ... August 15, 2019 , ... Serialization deadlines in ... become increasingly complex, and aggregation becomes fully applied in the United States in ... long-term solution. , Until now, most regulations?including the Drug Supply Chain Security Act ...
(Date:8/14/2019)... LAKE CITY, and MARTINSRIED, Germany (PRWEB) , ... ... ... in high-throughput antibody screening and characterization, announced today that they have opened a ... Carterra’s platform has fueled the need for the new office. , The Munich ...
Breaking Biology News(10 mins):
(Date:8/4/2019)... ... ... Cirtec Medical Corporation, a strategic outsourcing partner for complex medical devices, including active ... 30,000 sq. ft. manufacturing facility in the Coyol free zone, located in Alajuela, ... expected to be fully operational by the end of the year, will be the ...
(Date:7/19/2019)... ... July 18, 2019 , ... World renowned two-time Everest summiter ... with California-based charity Coalition Duchenne for its 9th Annual Expedition Mt. Kinabalu in ... funding for Duchenne muscular dystrophy and was founded by Sabahan Catherine Jayasuriya. ...
(Date:7/9/2019)... ... , ... Today, at the BIO World Congress on Industrial Biotechnology ... announced the winners of the Consider Corn Challenge II. Three winners were chosen, each ... produce biobased materials. , “Corn is a sustainable, abundant and affordable industrial ...
(Date:6/18/2019)... , ... June 18, 2019 , ... Personalized Stem ... New Drug (IND) application to the FDA for use of a person’s own adipose-derived ... a treatment of osteoarthritis in the knee. This IND is the first of ...
Breaking Biology Technology:
Cached News: